The communication reports the use of liquid crystalline networks (LCNs) for engineering tissue cultures with human cells. Their ability as cell scaffolds for different cell lines is demonstrated. Preliminary assessments of the material biocompatibility are performed on human dermal fibroblasts and murine muscle cells (C2C12), demonstrating that coatings or other treatments are not needed to use the acrylate-based materials as support. Moreover, it is found that adherent C2C12 cells undergo differentiation, forming multinucleated myotubes, which show the typical elongated shape, and contain bundles of stress fibers. Once biocompatibility is demonstrated, the same LCN films are used as a substrate for culturing human induced pluripotent stem cell-derived cardiomyocites (hiPSC-CMs) proving that LCNs are capable to develop adultlike dimensions and a more mature cell function in a short period of culture in respect to standard supports. The demonstrated biocompatibility together with the extraordinary features of LCNs opens to preparation of complex cell scaffolds, both patterned and stimulated, for dynamic cell culturing. The ability of these materials to improve cell maturation and differentiation will be developed toward engineered heart and skeletal muscular tissues exploring regenerative medicine toward bioartificial muscles for injured sites replacement.
Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair / Martella, Daniele; Paoli, Paolo; Pioner, JOSE' MANUEL; Sacconi, Leonardo; Coppini, Raffaele; Santini, Lorenzo; Lulli, Matteo; Cerbai, Elisabetta; Wiersma, DIEDERIK SYBOLT; Poggesi, Corrado; Ferrantini, Cecilia; Parmeggiani, Camilla. - In: SMALL. - ISSN 1613-6810. - ELETTRONICO. - 13:(2017), pp. 1-8. [10.1002/smll.201702677]
Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair
Daniele Martella;Paolo Paoli;Josè M. Pioner;Leonardo Sacconi;Raffaele Coppini;Lorenzo Santini;Matteo Lulli;Elisabetta Cerbai;Diederik S. Wiersma;Corrado Poggesi;Cecilia Ferrantini;And Camilla Parmeggiani
2017
Abstract
The communication reports the use of liquid crystalline networks (LCNs) for engineering tissue cultures with human cells. Their ability as cell scaffolds for different cell lines is demonstrated. Preliminary assessments of the material biocompatibility are performed on human dermal fibroblasts and murine muscle cells (C2C12), demonstrating that coatings or other treatments are not needed to use the acrylate-based materials as support. Moreover, it is found that adherent C2C12 cells undergo differentiation, forming multinucleated myotubes, which show the typical elongated shape, and contain bundles of stress fibers. Once biocompatibility is demonstrated, the same LCN films are used as a substrate for culturing human induced pluripotent stem cell-derived cardiomyocites (hiPSC-CMs) proving that LCNs are capable to develop adultlike dimensions and a more mature cell function in a short period of culture in respect to standard supports. The demonstrated biocompatibility together with the extraordinary features of LCNs opens to preparation of complex cell scaffolds, both patterned and stimulated, for dynamic cell culturing. The ability of these materials to improve cell maturation and differentiation will be developed toward engineered heart and skeletal muscular tissues exploring regenerative medicine toward bioartificial muscles for injured sites replacement.File | Dimensione | Formato | |
---|---|---|---|
Martella_et_al-2017-Small.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
2.92 MB
Formato
Adobe PDF
|
2.92 MB | Adobe PDF | Richiedi una copia |
Martella_et_al-2017-Small-1.pdf
accesso aperto
Tipologia:
Altro
Licenza:
Open Access
Dimensione
4.6 MB
Formato
Adobe PDF
|
4.6 MB | Adobe PDF | |
2158-1102556_preprint.pdf
accesso aperto
Tipologia:
Preprint (Submitted version)
Licenza:
Open Access
Dimensione
5.24 MB
Formato
Adobe PDF
|
5.24 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.